Herceptin

FirstWord Pharmaceutical News

14 years ago

FirstWord Pharmaceutical News for Friday, July 13, 2012

sanofi

glaxosmithkline

tykerb

herceptin

astrazeneca

+4

+4

+4

+3

+3

+2

+2

+1

12:00

sanofi

glaxosmithkline

tykerb

herceptin

astrazeneca

+4

+4

+4

+3

+3

+2

+2

+1

FirstWord Pharmaceutical News

12 years ago

FirstWord Pharmaceutical News for Wednesday, November 27, 2013

bayer

algeta

biocon

mylan

herceptin

+4

+4

+3

+3

+2

+1

06:23

bayer

algeta

biocon

mylan

herceptin

+4

+4

+3

+3

+2

+1

The Lancet: January 29, 2010

Listen to The Lancet

16 years ago

The Lancet: January 29, 2010

breast cancer

herceptin

chemotherapy

monoclonal antibodies

heart failure

+5

+5

+4

+4

+3

+3

+3

+2

+2

08:19

breast cancer

herceptin

chemotherapy

monoclonal antibodies

heart failure

+5

+5

+4

+4

+3

+3

+3

+2

+2

FirstWord Pharmaceutical News

13 years ago

FirstWord Pharmaceutical News for Tuesday, August 6, 2013

roche

herceptin

bayer

compugen

sanofi

+4

+4

+3

+3

+2

+2

+1

08:28

roche

herceptin

bayer

compugen

sanofi

+4

+4

+3

+3

+2

+2

+1

The Lancet: July 18, 2013

Listen to The Lancet

13 years ago

The Lancet: July 18, 2013

breast cancer

trastuzumab

herceptin

her2

radiotherapy

+5

+5

+4

+4

+3

+3

+2

+2

06:56

breast cancer

trastuzumab

herceptin

her2

radiotherapy

+5

+5

+4

+4

+3

+3

+2

+2

Cheaper breast cancer therapy

Health Report - Separate stori

9 years ago

Cheaper breast cancer therapy

breast cancer

trastuzumab

herceptin

biosimilar

survival

+5

+5

+4

+4

+3

+3

+2

+2

07:03

breast cancer

trastuzumab

herceptin

biosimilar

survival

+5

+5

+4

+4

+3

+3

+2

+2

FirstWord Pharmaceutical News

16 years ago

FirstWord Pharmaceutical News for Monday, August 23, 2010

stalevo

jzp-6

hospira

glaxosmithkline

herceptin

+4

+4

+3

+3

+2

+2

+2

+1

07:43

stalevo

jzp-6

hospira

glaxosmithkline

herceptin

+4

+4

+3

+3

+2

+2

+2

+1

The Lancet Oncology: December 16, 2014

Listen to The Lancet Oncology

11 years ago

The Lancet Oncology: December 16, 2014

breast cancer

oncology

palbociclib

herceptin

her2

+5

+5

+4

+4

+3

+3

+2

+2

breast cancer

oncology

palbociclib

herceptin

her2

+5

+5

+4

+4

+3

+3

+2

+2

The Lancet Oncology: March 01, 2011

Listen to The Lancet Oncology

15 years ago

The Lancet Oncology: March 01, 2011

breast cancer

herceptin

trastuzumab

her2 breast cancer

monoclonal antibody

+5

+5

+4

+4

+3

+3

+2

+2

+1

breast cancer

herceptin

trastuzumab

her2 breast cancer

monoclonal antibody

+5

+5

+4

+4

+3

+3

+2

+2

+1

FirstWord Pharmaceutical News

12 years ago

FirstWord Pharmaceutical News for Thursday, April 17, 2014

glaxosmithkline

roche

herceptin

reckitt benckiser

bioalliance pharma

+5

+5

+4

+3

+3

+3

+2

+2

+1

09:55

glaxosmithkline

roche

herceptin

reckitt benckiser

bioalliance pharma

+5

+5

+4

+3

+3

+3

+2

+2

+1